FDA Inspection 1275693 — Saint Luke's Hospital of Kansas City

Saint Luke's Hospital of Kansas City — FEI 1970696

The FDA completed an inspection of Saint Luke's Hospital of Kansas City on June 25, 2025 in Kansas City, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 25, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Kansas City, MO (United States)